-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998634 | Anti-DLL4 Reference Antibody (Smart Targeting patent anti-DLL4), Anti-DLL4 Reference Antibody (Smart Targeting patent anti-DLL4), |
|||
| A998635 | Anti-DPEP3 Reference Antibody (tamrintamab), Anti-DPEP3 Reference Antibody (tamrintamab), |
|||
| A998636 | Anti-DPP4 / CD26 Reference Antibody (begelomab), Anti-DPP4 / CD26 Reference Antibody (begelomab), |
|||
| A998637 | Anti-DSG3 Reference Antibody (Forerunner patent anti-DSG3), Anti-DSG3 Reference Antibody (Forerunner patent anti-DSG3), |
|||
| A998638 | Anti-Dysadherin Reference Antibody (Centrose patent anti-dysadherin), Anti-Dysadherin Reference Antibody (Centrose patent anti-dysadherin), |
|||
| A998639 | Anti-E8L Antibody (NL_A151), Anti-E8L Antibody (NL_A151), |
|||
| A998640 | Anti-EFNA4 Reference Antibody (PF-06647263), Anti-EFNA4 Reference Antibody (PF-06647263), |
|||
| A998641 | Anti-EGFL7 Reference Antibody (parsatuzumab), Anti-EGFL7 Reference Antibody (parsatuzumab), |
|||
| A666744 | Anti-EGFR & Fc-gamma-RIIIA Reference Antibody (AFM24), Target:EGFR&Fc-gamma-RIIIA,Uniprot:P00533&P08637,Species:Human,isotype:IgG-scFv Anti-EGFR & Fc-gamma-RIIIA Reference Antibody (AFM24), Target:EGFR&Fc-gamma-RIIIA,Uniprot:P00533&P08637,Species:Human,isotype:IgG-scFv |
|||
| A666785 | Anti-EGFR & HER3 Reference Antibody (Duligotuzumab), Target:EGFR&HER3,Uniprot:P00533&P21860,Species:Human,isotype:IgG-like Anti-EGFR & HER3 Reference Antibody (Duligotuzumab), Target:EGFR&HER3,Uniprot:P00533&P21860,Species:Human,isotype:IgG-like |
|||
| A666766 | Anti-EGFR & HER3 Reference Antibody (Izalontamab), Target:EGFR&HER3,Uniprot:P00533&P21860,Species:Human,isotype:IgG-scFv Anti-EGFR & HER3 Reference Antibody (Izalontamab), Target:EGFR&HER3,Uniprot:P00533&P21860,Species:Human,isotype:IgG-scFv |
|||
| A998642 | Anti-EMMPRIN / CD147 Reference Antibody (Centocor patent anti-CD147), Anti-EMMPRIN / CD147 Reference Antibody (Centocor patent anti-CD147), |
|||
| A998643 | Anti-Endoglin / CD105 Reference Antibody (carotuximab), Anti-Endoglin / CD105 Reference Antibody (carotuximab), |
|||
| A998644 | Anti-ENTPD1 / CD39 Reference Antibody (TTX-030), Anti-ENTPD1 / CD39 Reference Antibody (TTX-030), |
|||
| A998645 | Anti-EpCAM / TROP1 / CD326 Reference Antibody (adecatumumab), Anti-EpCAM / TROP1 / CD326 Reference Antibody (adecatumumab), |
|||
| A998646 | Anti-EpCAM / TROP1 / CD326 Reference Antibody (citatuzumab), Anti-EpCAM / TROP1 / CD326 Reference Antibody (citatuzumab), |
|||
| A998647 | Anti-EpCAM / TROP1 / CD326 Reference Antibody (oportuzumab), Anti-EpCAM / TROP1 / CD326 Reference Antibody (oportuzumab), |
|||
| A998648 | Anti-EphA2 Reference Antibody (MEDI-547), Anti-EphA2 Reference Antibody (MEDI-547), |
|||
| A998649 | Anti-EphA2 Reference Antibody (Sanofi Aventis patent anti-EphA2), Anti-EphA2 Reference Antibody (Sanofi Aventis patent anti-EphA2), |
|||
| A998650 | Anti-EphA3 Reference Antibody (ifabotuzumab), Anti-EphA3 Reference Antibody (ifabotuzumab), |
